Doximity (DOCS) Scheduled to Post Quarterly Earnings on Thursday

Doximity (NASDAQ:DOCS - Get Free Report) will announce its earnings results after the market closes on Thursday, November 7th. Analysts expect the company to announce earnings of $0.26 per share for the quarter. Doximity has set its FY 2025 guidance at EPS and its Q2 2025 guidance at EPS.Individual interested in participating in the company's earnings conference call can do so using this link.

Doximity (NASDAQ:DOCS - Get Free Report) last issued its earnings results on Thursday, August 8th. The company reported $0.22 EPS for the quarter, topping analysts' consensus estimates of $0.16 by $0.06. Doximity had a net margin of 32.53% and a return on equity of 19.26%. The company had revenue of $126.68 million for the quarter, compared to analysts' expectations of $119.88 million. On average, analysts expect Doximity to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Doximity Price Performance

NASDAQ DOCS traded down $0.25 during trading on Thursday, hitting $41.74. 1,033,309 shares of the company's stock traded hands, compared to its average volume of 1,667,970. The stock has a fifty day moving average of $40.44 and a two-hundred day moving average of $32.15. Doximity has a 12-month low of $19.89 and a 12-month high of $44.88. The firm has a market cap of $7.75 billion, a P/E ratio of 52.48, a PEG ratio of 5.29 and a beta of 1.29.

Wall Street Analyst Weigh In

A number of brokerages have commented on DOCS. Truist Financial reaffirmed a "hold" rating and issued a $35.00 price target (up from $31.00) on shares of Doximity in a research note on Wednesday, August 14th. Evercore ISI upped their price target on shares of Doximity from $34.00 to $45.00 and gave the company an "in-line" rating in a report on Tuesday, October 8th. Needham & Company LLC raised shares of Doximity from a "hold" rating to a "buy" rating and set a $38.00 price target on the stock in a report on Friday, August 9th. Baird R W upgraded shares of Doximity to a "strong-buy" rating in a research report on Tuesday, September 17th. Finally, Canaccord Genuity Group increased their target price on shares of Doximity from $37.00 to $40.00 and gave the stock a "buy" rating in a report on Tuesday, August 20th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating, five have issued a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $36.42.

Insider Buying and Selling

In other Doximity news, CFO Anna Bryson sold 30,000 shares of the firm's stock in a transaction on Friday, August 9th. The stock was sold at an average price of $35.00, for a total transaction of $1,050,000.00. Following the completion of the transaction, the chief financial officer now owns 309,627 shares of the company's stock, valued at approximately $10,836,945. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other Doximity news, CFO Anna Bryson sold 30,000 shares of the firm's stock in a transaction that occurred on Friday, August 9th. The shares were sold at an average price of $35.00, for a total transaction of $1,050,000.00. Following the completion of the transaction, the chief financial officer now owns 309,627 shares of the company's stock, valued at approximately $10,836,945. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Watkin Phoebe L. Yang sold 1,011 shares of the business's stock in a transaction that occurred on Monday, August 5th. The stock was sold at an average price of $25.54, for a total value of $25,820.94. Following the completion of the sale, the director now directly owns 11,258 shares in the company, valued at approximately $287,529.32. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 37.40% of the stock is owned by insiders.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.